Intercept Pharmaceuticals Inc (ICPT)
13.80
+0.13 (+0.95%)
USD |
NASDAQ |
Jun 30, 16:00
13.80
0.00 (0.00%)
After-Hours: 18:31
Intercept Pharmaceuticals Gross Profit Margin (Quarterly): 99.14% for March 31, 2022
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 99.14% |
| December 31, 2021 | 98.90% |
| September 30, 2021 | 99.29% |
| June 30, 2021 | 99.36% |
| March 31, 2021 | 99.01% |
| December 31, 2020 | 99.08% |
| September 30, 2020 | 97.70% |
| June 30, 2020 | 97.57% |
| March 31, 2020 | 98.83% |
| December 31, 2019 | 96.54% |
| September 30, 2019 | 99.21% |
| Date | Value |
|---|---|
| June 30, 2019 | 98.98% |
| March 31, 2019 | 98.90% |
| December 31, 2018 | 98.11% |
| September 30, 2018 | 98.90% |
| June 30, 2018 | 98.36% |
| March 31, 2018 | 99.22% |
| December 31, 2017 | 97.82% |
| September 30, 2017 | 99.58% |
| June 30, 2017 | 99.10% |
| March 31, 2017 | 99.54% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
96.54%
Minimum
Dec 2019
99.58%
Maximum
Sep 2017
98.68%
Average
98.94%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ocugen Inc | -- |
| Biohaven Pharmaceutical Holding Co Ltd | 91.74% |
| Cassava Sciences Inc | -- |
| Regeneron Pharmaceuticals Inc | 86.34% |
| Vertex Pharmaceuticals Inc | 88.28% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -13.15% |
| Return on Invested Capital | -18.80% |
| Profit Margin (Quarterly) | -19.51% |
| Operating Margin (Quarterly) | -11.60% |
| Return on Net Operating Assets | -43.23% |